Impact of treatment with biologic DMARDs on the risk of sepsis or mortality after serious infection in patients with rheumatoid arthritis.
about
What is the impact of biologic therapies on common co-morbidities in patients with rheumatoid arthritis?Trends of hospitalization for serious infections in patients with rheumatoid arthritis in the US between 1993 and 2013.RABBIT risk score and ICU admission due to infection in patients with rheumatoid arthritis.[Sepsis and mortality after severe infections : How epidemiological data confirm results of animal experiments].Response to: 'Biologic agents for giant cell arteritis: treat to target' by Moiseev et al.
P2860
Impact of treatment with biologic DMARDs on the risk of sepsis or mortality after serious infection in patients with rheumatoid arthritis.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Impact of treatment with biolo ...... nts with rheumatoid arthritis.
@en
Impact of treatment with biolo ...... nts with rheumatoid arthritis.
@nl
type
label
Impact of treatment with biolo ...... nts with rheumatoid arthritis.
@en
Impact of treatment with biolo ...... nts with rheumatoid arthritis.
@nl
prefLabel
Impact of treatment with biolo ...... nts with rheumatoid arthritis.
@en
Impact of treatment with biolo ...... nts with rheumatoid arthritis.
@nl
P2093
P2860
P1476
Impact of treatment with biolo ...... nts with rheumatoid arthritis.
@en
P2093
A Strangfeld
J Kaufmann
M Schneider
P2860
P304
P356
10.1136/ANNRHEUMDIS-2015-207838
P407
P577
2015-11-13T00:00:00Z